Delivery Order SPE2DX15D9245-SPE2DX23F5H2U

This is a $10,336.32 firm fixed-price delivery order contract awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, for the delivery of 4,568,568,836 units of BOTOX 100 UNIT VIALS. The contract has an ultimate completion date of July 8, 2025 and was awarded on June 13, 2025. The contract is not set-aside and allows for the delivery of both brand-name and generic medications. Amerisourcebergen Drug Corp holds a significant...

This is a firm fixed price delivery order awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation. The order is for 4,563,158,439 units of BOTOX 200 unit vials, with a potential value of $3,492.78 and a completion date of January 12, 2024. Amerisourcebergen Drug Corp is providing these pharmaceutical products to support DLA Troop Support Medical facilities. No set-aside designation was used for this award. Amerisourcebergen Drug...

This is a $5,168.16 firm fixed-price delivery order contract awarded to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, by the Defense Logistics Agency (DLA). The contract is for the delivery of 4,568,816,220 units of BOTOX 100 UNIT VIALS, with a period of performance through August 6, 2025. The contract is not set-aside and was competitively awarded. AmerisourceBergen Drug Corp holds a $999,999,999.00 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical,...

The Defense Logistics Agency (DLA) Troop Support Medical awarded a firm fixed price delivery order to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, to supply 4,562,737,471 units of BOTOX 200 unit vials. The $3,492.78 order is for delivery by November 28, 2023 and was awarded on November 3, 2023. Amerisourcebergen Drug Corp, through its Corporate Office division, is a prime contractor providing pharmaceutical products and medical supplies in support of DLA...

<p>The Defense Logistics Agency awarded a delivery order under an unspecified contract vehicle to DMS Pharmaceutical Group Inc. of Park Ridge, Illinois. The order is for 4559602505 units of BOTOX 100 unit vials with a potential value of two thousand seven hundred forty dollars and eighty cents ($2,740.80). The completion date is February 3, 2023. No set-aside designation was used for this award to procure the specified pharmaceutical products in support of DLA programs.</p>

This is a firm fixed-price delivery order contract awarded by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The contract, valued at $27,543.00, is for the delivery of 4,568,166,093 units of Botox 200 unit vials. The contract has an ultimate completion date of May 27, 2025. This delivery order is part of a larger Indefinite Delivery Contract (IDC) between DMS Pharmaceutical Group and the...

<p>This $3,805.08 firm fixed price delivery order was awarded by the Defense Logistics Agency to DMS Pharmaceutical Group Inc. of Park Ridge, Illinois on November 18, 2022. The order is for 4559158714 units of BOTOX 200 unit vials with performance required by December 12, 2022. No set-aside designation was applied to this procurement. DMS Pharmaceutical Group Inc. will deliver the contracted pharmaceutical products directly to the Defense Logistics Agency.</p>

This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of BOTOX 100 unit vials, with a ceiling value of $2,584.08 and a performance period ending on July 30, 2025. The contract is a Firm Fixed Price, non-set-aside delivery order. Amerisourcebergen Drug Corp holds a larger Indefinite Delivery Contract (IDC) with the DLA Troop Support...

This is a federal delivery order contract awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of 200-unit vials of BOTOX, a medication used for various medical and cosmetic purposes. The contract has a ceiling value of $12,821.85 and a completion date of July 16, 2025. The contract is a firm fixed-price delivery order, with no set-aside designation, indicating open...

This is a firm fixed-price delivery order contract awarded by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler. The contract, valued at $48,455.40, is for the delivery of 4,565,988,703 vials of Botox 100 unit injections. The period of performance runs through October 21, 2024. This delivery order is issued under DMS Pharmaceutical Group's existing indefinite delivery contract (IDC) with the DLA, valued at up to...